COVID-19 UPDATE

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

News Releases

News Releases

Date
Title
Document
February 13, 2014
BioDelivery Sciences Closes $60 Million Registered Direct Offering
PDF Version
February 10, 2014
BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors
PDF Version
January 30, 2014
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference
PDF Version
January 23, 2014
Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naïve Patients with Chronic Pain
PDF Version
January 10, 2014
BioDelivery Sciences Provides an Update of Anticipated 2014 Milestones
PDF Version

Investor Presentation

More information is coming soon.


Upcoming Events

More events are coming soon.

Stay Connected

Stay up to date on the latest news

Get started now
December 21, 2020 /
Data provided by West LLC. Minimum 15 minutes delayed.